Clinical Trial Update: Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sequential chemotherapy with Xelox followed by TX for gastric cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Eloxatin (oxaliplatin)
• TX

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN